Evidence map›Paper›PMID 20002189›Full record

ArticleFEMS microbiology letters2010

Biogenesis of Yersinia pestis PsaA in recombinant attenuated Salmonella Typhimurium vaccine (RASV) strain.

Ascención Torres-Escobar, María Dolores Juárez-Rodríguez, Roy Curtiss

Open access · bronzeAbstract read
In one paragraph

Article in FEMS microbiology letters, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Ascención Torres-EscobarCenter for Infectious Diseases and Vaccinology, The Biodesign Institute, School of Life Sciences, Arizona State University, Tempe, AZ, USA.
María Dolores Juárez-Rodríguez
Roy Curtiss
Arizona State University · US

Funding

Attenuated Live and Recombinant Yersinia Pestis VaccinesR01AI057885 · NIAID · WASHINGTON UNIVERSITY · PI CURTISS III, ROY · 2004 to 2014
$4.8M
NIAID NIH HHS AI057885NIAID NIH HHS R01 AI057885
6 · The paper itself

Abstract

Yersinia pestis PsaA is an adhesin important for the establishment of bacterial infection. PsaA synthesis requires the products of the psaEFABC genes. Here, by prediction analysis, we identified a PsaA signal sequence with two signal peptidase (SPase) cleavage sites, type-I and type-II (SPase-I and SPase-II). By Edman degradation and site-directed mutagenesis, the precise site for one of these Spase-I PsaA cleavage sites was located between alanine and serine at positions 31 and 32, respectively. Yersinia pestis psaA expression and the role of the PsaB and PsaC proteins were evaluated in recombinant attenuated Salmonella Typhimurium vaccine strains. PsaA was detected in total extracts as a major 15-kDa (mature) and 18-kDa (unprocessed) protein bands. PsaA synthesis was not altered by a DeltaA31-DeltaS32 double-deletion mutation. In contrast, the synthesis of PsaA (DeltaA31-DeltaS32) in Y. pestis and delivery to the supernatant was decreased. Otherwise, substitution of the amino acid cysteine at position 26 by valine involved in the SPase-II cleavage site did not show any effect on the secretion of PsaA in Salmonella and Yersinia. These results help clarify the secretion pathway of PsaA for the possible development of vaccines against Y. pestis.

Indexed as

Genetic VectorsAmino Acid SequenceAntigens, BacterialAspartic Acid EndopeptidasesBacterial ProteinsBase SequenceBinding SitesHumansMembrane ProteinsMolecular Sequence DataMutagenesis, Site-DirectedPlague VaccineProtein Sorting SignalsSalmonella typhimuriumSequence AlignmentSequence DeletionAntigens, BacterialAspartic Acid EndopeptidasesBacterial ProteinsMembrane ProteinspH 6 antigen, YersiniaPlague VaccineProtein Sorting SignalsSerine Endopeptidasessignal peptidase IItype I signal peptidaseVaccines, Synthetic

Identifiers

PMID20002189
PMCPMC2818566
OpenAlexW1933984238

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.